Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses

[1]  S. Nichol,et al.  High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses. , 2014, Antiviral research.

[2]  V. Lotteau,et al.  Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1. , 2014, Cell reports.

[3]  Wei Xu,et al.  The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway. , 2014, Cell reports.

[4]  A. McElroy,et al.  Development of a reverse genetics system to generate recombinant Marburg virus derived from a bat isolate. , 2013, Virology.

[5]  P. Rollin,et al.  Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012. , 2013, Virology.

[6]  H. Ebihara,et al.  Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. , 2013, Cell host & microbe.

[7]  I. Wilson,et al.  Ebolavirus VP35 Coats the Backbone of Double-Stranded RNA for Interferon Antagonism , 2013, Journal of Virology.

[8]  R. Compans,et al.  Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus , 2012, PLoS pathogens.

[9]  Z. Otwinowski,et al.  Structural basis for Marburg virus VP35–mediated immune evasion mechanisms , 2012, Proceedings of the National Academy of Sciences.

[10]  I. MacRae,et al.  Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism , 2012, PLoS pathogens.

[11]  Yali Zhu,et al.  Characterization of the RNA Silencing Suppression Activity of the Ebola Virus VP35 Protein in Plants and Mammalian Cells , 2012, Journal of Virology.

[12]  A. MacNeil,et al.  Using next generation sequencing to identify yellow fever virus in Uganda. , 2012, Virology.

[13]  A. McElroy,et al.  Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. , 2012, Virology.

[14]  D. Pala,et al.  dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35 , 2011, Antiviral Research.

[15]  V. Volchkov,et al.  VP24 is a molecular determinant of Ebola virus virulence in guinea pigs. , 2011, The Journal of infectious diseases.

[16]  W. Ian Lipkin,et al.  Discovery of an Ebolavirus-Like Filovirus in Europe , 2011, PLoS pathogens.

[17]  C. Basler,et al.  Filoviral Immune Evasion Mechanisms , 2011, Viruses.

[18]  J. Gonzalez,et al.  Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  A. Baum,et al.  Differential recognition of viral RNA by RIG-I , 2011, Virulence.

[20]  C. Basler,et al.  Marburg Virus VP40 Antagonizes Interferon Signaling in a Species-Specific Manner , 2011, Journal of Virology.

[21]  N. Sullivan,et al.  Ebolavirus Proteins Suppress the Effects of Small Interfering RNA by Direct Interaction with the Mammalian RNA Interference Pathway , 2011, Journal of Virology.

[22]  J. M. Binning,et al.  Basic Residues within the Ebolavirus VP35 Protein Are Required for Its Viral Polymerase Cofactor Function , 2010, Journal of Virology.

[23]  S. Nichol,et al.  Ebola and marburg hemorrhagic fever. , 2010, Clinics in laboratory medicine.

[24]  Z. Otwinowski,et al.  Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35 , 2010, Nature Structural &Molecular Biology.

[25]  V. Volchkov,et al.  Mutations Abrogating VP35 Interaction with Double-Stranded RNA Render Ebola Virus Avirulent in Guinea Pigs , 2010, Journal of Virology.

[26]  C. Basler,et al.  Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus , 2010, PLoS pathogens.

[27]  V. Volchkov,et al.  Ebolavirus VP24 Binding to Karyopherins Is Required for Inhibition of Interferon Signaling , 2009, Journal of Virology.

[28]  C. Basler,et al.  Ebola Virus Protein VP35 Impairs the Function of Interferon Regulatory Factor-Activating Kinases IKKε and TBK-1 , 2009, Journal of Virology.

[29]  J. Nix,et al.  Structure of the Ebola VP35 interferon inhibitory domain , 2009, Proceedings of the National Academy of Sciences.

[30]  S. Zaki,et al.  Inhibition of IRF-3 Activation by VP35 Is Critical for the High Level of Virulence of Ebola Virus , 2008, Journal of Virology.

[31]  C. Basler,et al.  Ebola Virus VP24 Proteins Inhibit the Interaction of NPI-1 Subfamily Karyopherin α Proteins with Activated STAT1 , 2007, Journal of Virology.

[32]  C. Basler,et al.  Ebola Virus VP 24 Proteins Inhibit the Interaction of NPI-1 Subfamily Karyopherin Proteins with Activated STAT 1 , 2007 .

[33]  S. Nichol,et al.  Reverse Genetic Generation of Recombinant Zaire Ebola Viruses Containing Disrupted IRF-3 Inhibitory Domains Results in Attenuated Virus Growth In Vitro and Higher Levels of IRF-3 Activation without Inhibiting Viral Transcription or Replication , 2006, Journal of Virology.

[34]  V. Volchkov,et al.  Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation , 2006, Journal of Virology.

[35]  Erica Ollmann Saphire,et al.  Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling , 2006, Journal of Virology.

[36]  V. Volchkov,et al.  Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. , 2006, Journal of virology.

[37]  S. Nichol,et al.  A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. , 2004, Virology.

[38]  Marcus Groettrup,et al.  Immunoproteasomes Down-Regulate Presentation of a Subdominant T Cell Epitope from Lymphocytic Choriomeningitis Virus1 , 2004, The Journal of Immunology.

[39]  S. Hazar,et al.  Filoviridae: Marburg and Ebola viruses. , 2000 .

[40]  S. Finke,et al.  Generation of Bovine Respiratory Syncytial Virus (BRSV) from cDNA: BRSV NS2 Is Not Essential for Virus Replication in Tissue Culture, and the Human RSV Leader Region Acts as a Functional BRSV Genome Promoter , 1999, Journal of Virology.

[41]  K. Ozato,et al.  Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). , 1996, Journal of biochemistry.